With the combined clinical and transcriptional data from TCGA concerning tobacco-related HNSCC patients, we observe that the nicotinic acetylcholine receptor subunit CHRNA5 corresponds with smoking history and may play both a prognostic and mechanistic role in HNSCC disease progression. This evidence concerns the gene CHRNA5 and head and neck squamous cell carcinoma.